Is Wall Street Bullish or Bearish on Zoetis Stock?

Valued at a market cap of $70.9 billion, Zoetis Inc. (ZTS) discovers, develops, manufactures, and commercializes animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions. The Parsippany, New Jersey-based company markets products for both livestock, such as cattle, swine, poultry, fish, and sheep, and companion animals, including dogs, cats, and horses.

Shares of this pets and livestock medicine producer have lagged behind the broader market over the past 52 weeks. Zoetis has fallen 5.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 8.6%. However, on a YTD basis, the stock is down 2.3%, outpacing SPX’s 3.8% drop.